Ubs Group Ag Aquestive Therapeutics, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 90,689 shares of AQST stock, worth $413,541. This represents 0.0% of its overall portfolio holdings.

Number of Shares

90,689

Previous 27,038 235.41%

Holding current value

$413,541

Previous $70,000 544.29%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.4 - $5.09 $152,762 - $323,983	63,651 Added 235.41%	90,689 $451,000
Q2 2024 Aug 13, 2024	BUY	$2.31 - $4.5 $57,837 - $112,671	25,038 Added 1251.9%	27,038 $70,000
Q1 2024 May 13, 2024	SELL	$2.01 - $6.09 $582 - $1,766	-290 Reduced 12.66%	2,000 $8,000
Q4 2023 Feb 09, 2024	BUY	$1.29 - $2.47 $2,954 - $5,656	2,290 New	2,290 $4,000
Q1 2023 May 12, 2023	BUY	$0.72 - $1.15 $2,695 - $4,305	3,744 New	3,744 $4,000
Q3 2022 Nov 10, 2022	BUY	$0.63 - $1.73 $5,451 - $14,969	8,653 Added 2085.06%	9,068 $11,000
Q2 2022 Aug 10, 2022	SELL	$0.64 - $2.57 $264 - $1,063	-414 Reduced 49.94%	415 $0
Q1 2022 May 16, 2022	SELL	$2.28 - $4.26 $2,576 - $4,813	-1,130 Reduced 57.68%	829 $2,000
Q4 2021 Feb 14, 2022	SELL	$3.69 - $6.37 $29,671 - $51,221	-8,041 Reduced 80.41%	1,959 $8,000
Q3 2021 Nov 15, 2021	SELL	$3.25 - $4.66 $13,195 - $18,919	-4,060 Reduced 28.88%	10,000 $44,000
Q2 2021 Aug 13, 2021	SELL	$3.29 - $5.21 $375 - $593	-114 Reduced 0.8%	14,060 $56,000
Q1 2021 May 12, 2021	SELL	$4.17 - $6.73 $40,011 - $64,574	-9,595 Reduced 40.37%	14,174 $74,000
Q4 2020 Feb 11, 2021	BUY	$4.65 - $7.79 $44,960 - $75,321	9,669 Added 68.57%	23,769 $128,000
Q3 2020 Nov 12, 2020	SELL	$4.12 - $9.09 $98,801 - $217,987	-23,981 Reduced 62.97%	14,100 $68,000
Q2 2020 Jul 31, 2020	BUY	$1.84 - $6.44 $34,763 - $121,670	18,893 Added 98.46%	38,081 $185,000
Q1 2020 May 01, 2020	BUY	$1.54 - $6.75 $14,149 - $62,019	9,188 Added 91.88%	19,188 $42,000
Q2 2019 Aug 14, 2019	SELL	$3.72 - $6.95 $12,357 - $23,087	-3,322 Reduced 24.94%	10,000 $42,000
Q1 2019 May 14, 2019	BUY	$5.74 - $8.05 $76,468 - $107,242	13,322 New	13,322 $92,000
Q4 2018 Feb 14, 2019	SELL	$6.09 - $18.0 $8,069 - $23,850	-1,325 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$15.0 - $18.96 $19,875 - $25,122	1,325 New	1,325 $23,000

Others Institutions Holding AQST

# of Institutions

122

Shares Held

46.8M

Call Options Held

517K

Put Options Held

207K

View Full List

About Aquestive Therapeutics, Inc.

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $243M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

More about AQST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account